Results 181 to 190 of about 2,743,257 (209)
Some of the next articles are maybe not open access.

HCV core antigen and the time of HCV inf

2004
Backgroung: antibody tests are unable to identify subjects in the early stage of infection (window period) during which specific antibodies have not yet been produced. This stage (preseroconversion period) may last up to 2 months in immunocompetent and as long as 6 to 12 months in immunodeficient patients.
openaire  

HCV core antigen assay

Transfusion, 2001
Pier Luigi Piccoli   +6 more
openaire   +1 more source

HCV core antigen as an alternative to NAT to detect HCV viremia

Transfusion, 2004
Christina A, Raker   +7 more
openaire   +2 more sources

Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valadè   +2 more
exaly  

HCV NAT (minipool RT‐PCR) and HCV core antigen ELISA

Transfusion, 2003
Adolfo Eiras   +4 more
openaire   +1 more source

Clinical significance of HCV core antigen, a new marker of HCV infection

Journal of Hepatology, 2002
Magali Bouvier-Alias   +10 more
openaire   +1 more source

CONJUGATES OF (ACRIDINIUM)x-BSA ANTI-HCV CORE TO ENHANCE THE DETECTION OF HCV CORE ANTIGEN

Bioluminescence and Chemiluminescence, 2008
C. D. CHANG   +4 more
openaire   +1 more source

Performance of ARCHITECT HCV Core Antigen Test With Specimens From US Plasma Donors and Injecting Drug Users

Journal of Clinical Virology, 2015
Eyasu Teshale, Saleem Kamili, John Ward
exaly  

Home - About - Disclaimer - Privacy